These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 11207263)

  • 1. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
    J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
    Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
    J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
    Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
    J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
    Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
    Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.
    Suzuki H; Sekine S; Kataoka K; Pascual DW; Maddaloni M; Kobayashi R; Fujihashi K; Kozono H; McGhee JR; Fujihashi K
    Gastroenterology; 2008 Sep; 135(3):917-25. PubMed ID: 18565333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
    Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
    Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for early aging in the mucosal immune system.
    Koga T; McGhee JR; Kato H; Kato R; Kiyono H; Fujihashi K
    J Immunol; 2000 Nov; 165(9):5352-9. PubMed ID: 11046071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
    Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
    J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47-deficient mice have decreased production of intestinal IgA following oral immunization but a maintained capacity to induce oral tolerance.
    Westlund J; Livingston M; Fahlén-Yrlid L; Oldenborg PA; Yrlid U
    Immunology; 2012 Mar; 135(3):236-44. PubMed ID: 22070457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
    Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
    J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANTES potentiates antigen-specific mucosal immune responses.
    Lillard JW; Boyaka PN; Taub DD; McGhee JR
    J Immunol; 2001 Jan; 166(1):162-9. PubMed ID: 11123289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
    Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC
    J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peyer's patches are required for oral tolerance to proteins.
    Fujihashi K; Dohi T; Rennert PD; Yamamoto M; Koga T; Kiyono H; McGhee JR
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3310-5. PubMed ID: 11248075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
    Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
    Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired mucosal immune responses in interleukin 4-targeted mice.
    Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N
    J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
    Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
    J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO; Ealding W
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.
    Yamamoto S; Kiyono H; Yamamoto M; Imaoka K; Fujihashi K; Van Ginkel FW; Noda M; Takeda Y; McGhee JR
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5267-72. PubMed ID: 9144226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice.
    Kweon MN; Fujihashi K; VanCott JL; Higuchi K; Yamamoto M; McGhee JR; Kiyono H
    J Immunol; 1998 Feb; 160(4):1687-93. PubMed ID: 9469425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.